CCEL Q3 2024 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q3 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+2.5% YoY

Gross Profit

$6M73.6% margin

Operating Income

$1M17.2% margin

Net Income

$1M13.0% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$145,941

Balance Sheet

Total Assets

$63M

Total Liabilities

$72M

Stockholders' Equity

-$10M

Cash & Equivalents

$197,437

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+2.5%
Gross Profit	$6M	$6M	+4.0%
Operating Income	$1M	$1M	+19.7%
Net Income	$1M	$680,561	+54.5%

Revenue Segments

Processing And Storage Fees

$8M98%

Public Banking

$120,6091%

Product

$6360%